Can this little Aussie tech stock be the next Cochlear?




Is this little aussie tech company the next Cochlear?

CEO Philip Daffas explains to InsideMarket.net how and why he believes it could track the same way.

Daffas is the former VP of Marketing at CochlearGlobal Marketing Manager Roche and now CEO of Painchek (ASX:EPT)


9 views
  • LinkedIn Social Icon
  • Twitter Social Icon

Through our InsideMarket Tech Fund we may have holdings in companies we report on. However, we do not receive any payment for coverage on insidemarket.net